Evidence map›Paper›PMID 27984525›Full record

ArticlePain2017

Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study.

Inna E Tchivileva, Richard Ohrbach, Roger B Fillingim, Joel D Greenspan, William Maixner, Gary D Slade

Open access · greenAbstract read
In one paragraph

Article in Pain, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. An Update on Temporomandibular Disorders (TMDs) and Headache.Current neurology and neuroscience reports · 2023
    Review
  15. Review
  16. Recent Advances in Temporomandibular Joint Surgery.Medicina (Kaunas, Lithuania) · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Inna E TchivilevaCenter for Pain Research and Innovation, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Richard OhrbachDepartment of Oral Diagnostic Sciences, University at Buffalo, Buffalo, NY, USA.
Roger B FillingimDepartment of Community Dentistry and Behavioral Science, University of Florida, College of Dentistry, and Pain Research and Intervention Center of Excellence, Gainesville, FL, USA.
Joel D GreenspanDepartment of Neural and Pain Sciences, School of Dentistry, University of Maryland, Baltimore, MD, USA.
William MaixnerCenter for Translational Pain Medicine, Duke University, Durham, NC, USA.
Gary D SladeCenter for Pain Research and Innovation, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · USDuke University · USUniversity at Buffalo, State University of New York · USUniversity of Florida · USUniversity of Maryland, Baltimore · US

Funding

Risk Factors for Onset and Persistence of TMDU01DE017018 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DIATCHENKO, LUDA, FILLINGIM, ROGER B · 2005 to 2016
$35.9M
University of Florida Older Americans Independence Center (OAIC)P30AG028740 · NIA · UNIVERSITY OF FLORIDA · PI CHRISTIAAN LEEUWENBURGH · 2007 to 2026
$22.8M
Biomedical Researcher Development Program in TMJD and Orofacial PainK12DE022793 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIM, PEI FENG, MAIXNER, WILLIAM · 2012 to 2016
$1.3M
NIA NIH HHS P30 AG028740NIDCR NIH HHS K12 DE022793NIDCR NIH HHS U01 DE017018
6 · The paper itself

Abstract

While cross-sectional studies have demonstrated an association between headache and temporomandibular disorder (TMD), whether headache can predict the onset of TMD is unknown. The aims of this study were to evaluate the contribution of headache to the risk of developing TMD and describe patterns of change in headache types over time. An initially TMD-free cohort of 2410 persons with low frequency of headache completed quarterly questionnaires assessing TMD and headache symptoms over a median 3.0-year follow-up period. First-onset TMD was confirmed by clinical examination in 199 participants. Baseline reports of migraine (hazard ratio [HR] = 1.67, 95% confidence interval [CI]: 1.06-2.62) or mixed headache types (HR = 4.11, 95% CI: 1.47-11.46), or headache frequency (HR = 2.13, 95% CI: 1.31-3.48) predicted increased risk of developing TMD. In addition, headache dynamics across the follow-up period before the TMD onset were evaluated in a nested case-control study where 248 incident TMD cases were matched to 191 TMD-free controls. Both headache prevalence and frequency increased across the observation period among those who developed TMD but not among controls. Patients with TMD were more likely to experience worsening in the headache type compared with that by controls, eg, prevalence of definite migraine among TMD cases increased 10-fold. Among all headache types experienced by patients with TMD before the TMD onset, migraine had the highest odds of progression relative to remission (odds ratio = 2.8, 95% CI: 1.6-4.8), whereas for controls this ratio was significant only for the tension-type headache (odds ratio = 2.1, 95% CI: 1.2-3.9). The important clinical implication of these findings is that adequate treatment of migraine may reduce the risk for developing TMD.

Indexed as

AdolescentAdultAge FactorsCase-Control StudiesCohort StudiesCross-Sectional StudiesDisease ProgressionFacial PainFemaleHeadacheHumansInterviews as TopicMalePain MeasurementRisk AssessmentRisk Factors

Identifiers

PMID27984525
PMCPMC5639910
OpenAlexW2567641473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.